![[PDF]](/pb-assets/Icons/adobe-pdf-icon-1498649896243.png){kind=icon}
Abstract
Successful induction of antiphospholipid syndrome (APS) in two different non-autoimmune prone mouse strains, BALB/c and C57BL/6, was achieved by tetanus toxoid (TTd) hyperimmunization using different adjuvants (glycerol or aluminium hydroxide), and different adjuvant pretreatments (glycerol or Complete Freund’s Adjuvant (CFA)). APS had different manifestations of reproductive pathology in BALB/c and C57BL/6 mice: fetal resorption (as a consequence of extreme T-cell activation obtained in the course of pretreatment), and lowering of fecundity (as a consequence of polyclonal B-cell stimulation), respectively. In BALB/c mice fetal resorption coincided with glycerol and CFA pretreatments, while in C57BL/6 mice lowering of fecundity was most obvious in CFA-pretreated mice immunized with TTd in aluminium hydroxide. Both molecular mimicry and polyclonal B-cell activation occur in APS induction, with molecular mimicry effects being dominant in BALB/c mice, and polyclonal cell activation being dominant in C57BL/6 mice. Confirmation of molecular mimicry effects, which in the condition of T-cell stimulation generated fetal resorptions in the BALB/c strain, was achieved by passive infusion of monoclonal antibody (MoAb) T-26 specific for TTd and anti-β2-glycoprotein I obtained after TTd hyperimunization. High polyclonal B-cell activation in C57BL/6 mice prevented fetal resorption but induced fecundity lowering, as was the case in passive administration of MoAb T-26 in this mouse strain. Passive infusion of anti-idiotypic MoAb Y7 into C57BL/6 mice induced fetal resorptions and confirmed the above suggestion on the protective role of polyclonal B-cell stimulation in fetal resorptions.
References
| 1. | Radway-Bright, EL, Inanc, M, Isenberg, DA. Animal models of the antiphospholipid syndrome. Rheumatology 1999; 38: 591–601. Google Scholar | Crossref | Medline | ISI |
| 2. | Ahmadi, K, Wilson, C, Tiwana, H. Antibodies to Klebsiella pneumoniae lipopolysaccharide in patients with ankylosing spondylitis. Rheumatology 1998; 37: 1330–1333. Google Scholar | Crossref | ISI |
| 3. | Bogdanos, DP, Mieli-Vergani, G, Vergani, D. Non-organ-specific autoantibodies in hepatitis C virus infection: do they matter? Clin Infect Dis 2005; 40: 508–510. Google Scholar | Crossref | Medline | ISI |
| 4. | Chen, LK, Chou, YC, Tsai, ST. Hepatitis C virus infection related Type 1 diabetes mellitus. Diabet Med 2005; 22: 340–343. Google Scholar | Crossref | Medline | ISI |
| 5. | Tiwana, H, Wilson, C, Alvarez, A. Crossreactivity between the rheumatoid arthritis-associated motif EQKRAA and structurally related sequences found in Proteus mirabilis. Infect Immun 1999; 67: 2769–2775. Google Scholar | Crossref | Medline | ISI |
| 6. | Khamaisi, M, Shoenfeld, Y, Orbach, H. Guillain-Barre syndrome following hepatitis B vaccination. Clin Exp Rheumatol 2004; 22: 767–770. Google Scholar | Medline | ISI |
| 7. | Mari, A . Is there a causative role of tetanus toxoid vaccination in the development of allergy-like symptoms and the increasing prevalence of atopic diseases? Med Hypotheses 2004; 63: 875–886. Google Scholar | Crossref | Medline | ISI |
| 8. | Selmi, C, Battezzati, PM, Gershwin, ME. Vaccines in 21st century: the genetic response and the innocent bystander. Autoimmun Rev 2005; 4: 79–81. Google Scholar | Crossref | Medline | ISI |
| 9. | Toplak, N, Avcin, T. Vaccination of healthy subjects and autoantibodies: from mice through dogs to humans. Lupus 2009; 18: 1186–1191. Google Scholar | SAGE Journals | ISI |
| 10. | Shoenfeld, Y . Infections, vaccines and autoimmunity. Lupus 2009; 18: 1127–1128. Google Scholar | SAGE Journals | ISI |
| 11. | Blank, M, Krause, I, Fridkin, M. Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for infectious etiology of antiphospholipid syndrome. J Clin Invest 2002; 109: 797–804. Google Scholar | Crossref | Medline | ISI |
| 12. | Blank, M, Eisenstein, M, Ascherson, RA, Cervera, R, Schoenfeld, Y. The infectious origin of the antiphospholipid syndrome. In: Schoenfeld, Y, Rose, N (eds). Infection and Autoimmunity Amsterdam: Elsevier; 2004. 473–490. Google Scholar | Crossref |
| 13. | Meroni, PL . Pathogenesis of the antiphospholipid syndrome: An additional example of the mosaic of autoimmunity. J Autoimmun 2008; 30: 99–103. Google Scholar | Crossref | Medline | ISI |
| 14. | Billiau, A, Matthys, P. Modes of action of Freud’s adjuvants in experimental models of autoimmune diseases. J Leuk Biol 2001; 70: 849–860. Google Scholar | Medline | ISI |
| 15. | Stills, HF . Adjuvants and antibody production: dispelling the myths associated with Freund's complete and other adjuvants. ILAR J 2005; 46: 280–293. Google Scholar | Crossref | Medline | ISI |
| 16. | Barton, GM, Medzhitov, R. Control of adaptive immune responses by Toll-like receptors. Curr Opin Immunol 2002; 14: 380–383. Google Scholar | Crossref | Medline | ISI |
| 17. | Pulendran, B . Modulating vaccine responses with dendritic cells and Toll-like receptors. Immunol Rev 2004; 199: 227–250. Google Scholar | Crossref | Medline | ISI |
| 18. | Netea, MG, Kullberg, BJ, de Jong, D. NOD2 mediates induction of the antiinflammatory signals induced by TLR2-ligands: implications for Crohn’s disease. Eur J Immunol 2004; 34: 2052–2059. Google Scholar | Crossref | Medline | ISI |
| 19. | Duan, B, Morel, L. Role of B-1a cells in autoimmunity. Autoimmun Rev 2006; 5: 403–408. Google Scholar | Crossref | Medline | ISI |
| 20. | Ghumman, B, Bertram, EM, Watts, TH. Chemical chaperones enhance superantigen and conventional antigen presentation by HLA-DM-deficient as well as HLA-DM-sufficient antigen-presenting cells and enhance IgG2a production in vivo. J Immunol 1998; 161: 3262–3270. Google Scholar | Medline | ISI |
| 21. | Brewer, JM . (How) do aluminum adjuvants work? Immunol Lett 2006; 102: 10–15. Google Scholar | Crossref | Medline | ISI |
| 22. | Lindblad, EB . Freund’s adjuvants. In: O’Hagan, DT (eds). Methods in molecular medicine: vaccine adjuvants—preparation methods and research protocols Totowa NJ: Humana Press; 2000. 49–63. Google Scholar | Crossref |
| 23. | Krieglstein, KG, Henschen, AH, Weller, U. Limited proteolysis of tetanus toxin. Relation to activity and identification of cleavage sites. Eur J Biochem 1991; 202: 41–51. Google Scholar | Crossref | Medline |
| 24. | European Bioinformatics Institute – European Molecular Biology Laboratory [Internet], Cambridgeshire, UK, [cited 2008 June 2]. Available from http://www.ebi.ac.uk/t-coffee/. Google Scholar |
| 25. | Farrar, JJ, Yen, LM, Cook, T. Neurological aspects of tropical disease: Tetanus. J Neurol Neurosurg Psychiatry 2000; 69: 292–301. Google Scholar | Crossref | Medline | ISI |
| 26. | Shibuya, K, Robinson, D, Zonin, F. IL-1 alpha and TNF-alpha are required for IL-12-induced development of Th1 cells producing high levels of IFN-gamma in BALB/c but not C57BL/6 mice. J Immunol 1998; 160: 1708–1716. Google Scholar | Medline | ISI |
| 27. | Zhang, F, Liang, Z, Matsuki, N. A murine locus on chromosome 18 controls NKT cell homeostasis and Th cell differentiation. J Immunol 2003; 171: 4613–4620. Google Scholar | Crossref | Medline | ISI |
| 28. | International Immunogenetics Information System. http://www.imgt.org/IMGTrepertoire/ LocusGenes/index.php? repertoire=nomenclatures&species=mouse&group=IGHV. Google Scholar |
| 29. | Haines, BB, Angeles, CV, Parmelee, AP, McLean, PA, Brodeur, PH. Germline diversity of the expressed BALB/c VhJ558 gene family. Mol Immunol 2001; 38: 9–18. Google Scholar | Crossref | Medline | ISI |
| 30. | Yancopoulos, DG, Malynn, AB, Alt, FW. Developmentally regulated and strain-specific expression of murine Vh gene families. J Exp Med 1988; 168: 417–435. Google Scholar | Crossref | Medline | ISI |
| 31. | Seidl, KJ, Wilshire, JA, Mackenzie, JD, Kantor, AB, Herzenberg, LA, Herzenberg, LA. Predominant VH genes expressed in innate antibodies are associated with distinctive antigen-binding sites. Proc Natl Acad Sci U S A 1999; 96: 2262–2267. Google Scholar | Crossref | Medline | ISI |
| 32. | Pellegrini, A, Guiñazú, N, Aoki, MP. Spleen B cells from BALB/c are more prone to activation than spleen B cells from C57BL/6 mice during a secondary immune response to cruzipain. Int Immunol 2007; 19: 1395–1402. Google Scholar | Crossref | Medline | ISI |
| 33. | Won, W-J, Kearney, JF. CD9 is a unique marker for marginal zone B cells, B1 cells, and plasma cells in mice. J Immunol 2002; 168: 5605–5611. Google Scholar | Crossref | Medline | ISI |
| 34. | Lampropoulou, V, Hoehlig, K, Roch, T. TLR-activated B cells suppress T cell-mediated autoimmunity. J Immunol 2008; 180: 4763–4773. Google Scholar | Crossref | Medline | ISI |
| 35. | Pellegrini, A, Carrera-Silva, EA, Arocena, A. Trypanosoma cruzi antigen immunization induces a higher B cell survival in BALB/c mice, a susceptible strain, compared to C57BL/6 B lymphocytes, a resistant strain to cardiac autoimmunity. Med Microbiol Immunol 2011. (in press). Google Scholar | Crossref | Medline | ISI |
| 36. | Shoenfeld, Y, Aron-Maor, A. Vaccination and autoimmunity – ‘vaccinosis’: a dangerous liaison? J Autoimmun 2000; 14: 1–10. Google Scholar | Crossref | Medline | ISI |
| 37. | Stojanović, M, Zivković, I, Inić-Kanada, A. The context of tetanus toxoid application influences the outcome of antigen-specific and self-directed humoral immune response. Microbiol Immunol 2009; 53: 89–100. Google Scholar | Crossref | Medline | ISI |
| 38. | Zivkovic, I, Stojanovic, M, Petrusic, V. Induction of APS after TTd hyper-immunization has a different outcome in BALB/c and C57BL/6 mice. Am J Reprod Immunol 2011; 65: 492–502. Google Scholar | Crossref | Medline | ISI |
| 39. | Živković, I, Petrušić, V, Stojanović, M. Induction of decreased fecundity by tetanus toxoid hyper-immunization in C57BL/6 mice depends on the applied adjuvant. Innate Immun. (in press). Google Scholar | ISI |
| 40. | Zivkovic, IP, Stojanovic, MM, Petrusic, VZ. Network connectivity is shown to change in C57BL/6 mice during a continuing immune response subsequent to tetanus toxoid hyperimmunization. Biol Res 2010; 43: 393–402. Google Scholar | Crossref | Medline | ISI |
| 41. | Radulovic, M, Ciric, B, Jurisic, A. Expression of Y7 idiotope on IgM molecules from cord sera. In: Lukic, M, Mostarica-Stojkovic, M, Cuperlovic, K, Colic, M (eds). Immune regulation in health and disease London: Academic Press; 1997. 205–211. Google Scholar | Crossref |
| 42. | Ivanovic, V, Popovic, L, Kovacina, K. Detection of cross-reacting idiotypes in sera of lymphoma patients by inverse monoclonal radioimmunoassay. Acta Haematol 1990; 84: 64–67. Google Scholar | Crossref | Medline | ISI |
| 43. | Dimitrijevic, LA, Radulovic, MI, Ciric, BP. Human monoclonal IgM DJ binds to ssDNA and human commensal bacteria. Hum Antibodies 1999; 9: 37–45. Google Scholar | Crossref | Medline |
| 44. | Dimitrijevic, LA, Stojanovic, M, Ciric, B. Expression of Y7 cross-reactive idiotope on human IgM molecules. Immunol Invest 2004; 33: 1–14. Google Scholar | Crossref | Medline | ISI |
| 45. | Dimitrijevic, L, Radulovic, M, Ciric, B. Immunochemical characterization of a murine monoclonal anti-idiotypic antibody. J Immunoassay 1992; 13: 181–196. Google Scholar | Crossref | Medline |
| 46. | Giannakopoulos, B, Passam, F, Rahgozar, S, Krilis, SA. Current concepts on the pathogenesis of the antiphospholipid syndrome. Blood 2007; 109: 422–430. Google Scholar | Crossref | Medline | ISI |
| 47. | Galili, U . Alpha-galactosyl (anti-Gal) autoantibodies. In: Peter, JB, Shoenfeld, Y (eds). Autoantibodies Amsterdam: Elsevier; 1996. 24–30. Google Scholar | Crossref |
| 48. | Raschi, E, Testoni, C, Bosisio, D. Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies. Blood 2003; 101: 3495–3500. Google Scholar | Crossref | Medline | ISI |
| 49. | Inic-Kanada, A, Stojanovic, M, Zivkovic, I. Murine monoclonal antibody 26 raised against tetanus toxoid cross-reacts with beta2-glycoprotein I: its characteristics and role in molecular mimicry. Am J Reprod Immunol 2009; 61: 39–51. Google Scholar | Crossref | Medline | ISI |
